Matrix Capital Management Company, LP - Q1 2022 holdings

$8.33 Billion is the total value of Matrix Capital Management Company, LP's 25 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 50.0% .

 Value Shares↓ Weighting
DIS BuyDISNEY WALT CO$868,223,000
+33.5%
6,330,000
+50.7%
10.42%
+43.9%
NFLX  NETFLIX INC$749,180,000
-37.8%
2,000,0000.0%8.99%
-33.0%
TDG  TRANSDIGM GROUP INC$713,371,000
+2.4%
1,094,9000.0%8.56%
+10.4%
CRWD  CROWDSTRIKE HLDGS INCcl a$681,240,000
+10.9%
3,000,0000.0%8.18%
+19.6%
BuyGLOBALFOUNDRIES INCordinary shares$572,897,000
+487.9%
9,178,100
+511.9%
6.88%
+533.8%
CRM  SALESFORCE COM INC$556,769,000
-16.5%
2,622,3090.0%6.68%
-9.9%
ALTR  ALTAIR ENGR INC$553,840,000
-16.7%
8,600,0000.0%6.65%
-10.2%
QCOM  QUALCOMM INC$510,015,000
-16.4%
3,337,3600.0%6.12%
-9.9%
TWLO BuyTWILIO INCcl a$431,398,000
-11.2%
2,617,549
+41.8%
5.18%
-4.3%
AMAT BuyAPPLIED MATLS INC$423,473,000
-10.7%
3,213,000
+6.6%
5.08%
-3.7%
AMD NewADVANCED MICRO DEVICES INC$395,717,0003,619,140
+100.0%
4.75%
NEWR  NEW RELIC INC$334,400,000
-39.2%
5,000,0000.0%4.01%
-34.4%
MU  MICRON TECHNOLOGY INC$311,560,000
-16.4%
4,000,0000.0%3.74%
-9.8%
WDAY BuyWORKDAY INCcl a$268,445,000
-6.9%
1,121,043
+6.2%
3.22%
+0.3%
ZNTL  ZENTALIS PHARMACEUTICALS INC$200,676,000
-45.1%
4,349,2790.0%2.41%
-40.8%
XBI NewSPDR SER TRs&p biotech$188,748,0002,100,000
+100.0%
2.27%
ADPT  ADAPTIVE BIOTECHNOLOGIES COR$160,628,000
-50.5%
11,572,5900.0%1.93%
-46.7%
 AURA BIOSCIENCES INC$90,483,000
+29.6%
4,112,8700.0%1.09%
+39.8%
 PERIMETER SOLUTIONS SA$90,371,000
-12.8%
7,462,5000.0%1.08%
-6.0%
S NewSENTINELONE INCcl a$87,165,0002,250,000
+100.0%
1.05%
ADAP  ADAPTIMMUNE THERAPEUTICS PLCsponds adr$80,287,000
-45.1%
38,974,1850.0%0.96%
-40.7%
ARKG NewARK ETF TRgenomic rev etf$45,930,0001,000,000
+100.0%
0.55%
ADCT NewADC THERAPEUTICS SA$5,876,000400,000
+100.0%
0.07%
NewIMAGO BIOSCIENCES INC$5,936,000308,044
+100.0%
0.07%
NewVENTYX BIOSCIENCES INC$4,546,000335,000
+100.0%
0.06%
ExitFORGEROCK INCcl a$0-1,000,000
-100.0%
-0.30%
DT ExitDYNATRACE INC$0-652,500
-100.0%
-0.44%
ExitAMPLITUDE INC$0-1,607,400
-100.0%
-0.95%
XLNX ExitXILINX INC$0-2,100,000
-100.0%
-4.96%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC42Q3 202313.3%
WORKDAY INC42Q3 202319.7%
NETFLIX INC37Q2 202226.1%
NEW RELIC INC29Q1 20227.8%
DAVITA INC26Q3 20196.1%
ADAPTIMMUNE THERAPEUTICS PLC26Q3 20236.8%
SALESFORCE INC23Q3 202218.4%
CONSTELLATION BRANDS INC23Q2 20195.7%
AMAZON COM INC21Q3 202311.2%
TABLEAU SOFTWARE INC20Q2 201915.2%

View Matrix Capital Management Company, LP's complete holdings history.

Latest significant ownerships (13-D/G)
Matrix Capital Management Company, LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Adaptimmune Therapeutics PLCJuly 10, 2023233,845,11017.3%
Zentalis Pharmaceuticals, Inc.June 20, 202313,959,97319.8%
ForgeRock, Inc.Sold outFebruary 13, 202300.0%
NEW RELIC, INC.Sold outFebruary 13, 202300.0%
Perimeter Solutions, SAFebruary 13, 20238,587,5005.4%
Aura Biosciences, Inc.December 07, 20225,362,87014.5%
Adaptive Biotechnologies CorpFebruary 14, 202211,572,5908.2%
BigCommerce Holdings, Inc.Sold outFebruary 14, 202200.0%
CarGurus, Inc.Sold outFebruary 16, 202100.0%
Trillium Therapeutics Inc.Sold outFebruary 14, 202000.0%

View Matrix Capital Management Company, LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
42023-11-09
SC 13D/A2023-11-09
13F-HR2023-08-14
SC 13G/A2023-07-10
42023-06-20
SC 13D/A2023-06-20
13F-HR2023-05-15

View Matrix Capital Management Company, LP's complete filings history.

Compare quarters

Export Matrix Capital Management Company, LP's holdings